Sherwin Isenberg, MD
Gerber Professor of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine at UCLA
Founder and Council member: International Pediatric Ophthalmology and Strabismus Council
The mission is to prevent childhood blindness
Research DescriptionDr. Isenberg is developing a conjunctival tissue gas monitor to measure all blood gases. His goal is to reduce blindness in newborns caused by Retinopathy of Prematurity by better controlling their oxygen and other gases. The treatment can also be used in emergency rooms, operating rooms, intensive care units and on the battlefield to direct care and potentially save lives.
Additionally, Dr. Isenberg is using povidone-iodine ophthalmic solution to prevent and treat trachoma which blinds more than ten million people. This prospective trial would be conducted in Ethiopia. It is the culmination of our numerous studies which have proven the eye drop effective before and after surgery, for newborn prophylaxis, and again conjunctivitis and corneal infections. The use of this L.A. BioMed developed eye drop annually prevents thousands of eyes undergoing routine surgery from going blind.
- BS, 1969, University of California, Los Angeles
- MD, 1973, University of California, Los Angeles
Recent and/or Significant Publications
- Weiss IK, Isenberg SJ, McArthur DL, Del Signore M, McDonald J. Monitoring Conjunctival pH, Carbon Dioxide, and Oxygen Tensions During Cardio-Pulmonary Bypass, Journal of ExtraCorporeal Technology 43:13-19, 2011
- Isenberg SJ, Neumann D, Fink S, Rich R., Continuous oxygen monitoring of the conjunctiva in neonates., J Perinatology 22:46-49, 2002.
- Isenberg SJ, Apt L, Valenton M, Del Signore M, Cubillan L, Labrador MA, Chan P, Berman NG. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol 134:681-688, 2002.
- Isenberg SJ, Apt L, and Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. New England J. Med. 332:562-6, 1995.